Allen v. Takeda Pharmaceuticals North America
A jury in Lousiana awarded more than $9 billion to a New York couple in a bellwether trial in federal court over claims that taking diabetes drug Actos increases the risk of bladder cancer. The April 7 verdict, the first of 3,000-plus lawsuits coordinated before U.S. District Judge Rebecca Doherty in Lafayette, La., is bad news for defendants Takeda Pharmaceuticals USA Inc. and Eli Lilly & Co. They are represented by Sara Gourley at Sidley Austin and Bruce Parker at Venable, who tried the case together and are jointly overseeing the litigation.
